BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹3.66 Cr | ₹0.04 Cr | ₹0.01 Cr | ₹0.00 Cr | - |
What is the latest Total Non-Current Liabilities ratio of BALAXI PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2023 | ₹3.66 Cr |
Mar2022 | ₹0.04 Cr |
Mar2021 | ₹0.01 Cr |
Mar2020 | ₹0.00 Cr |
Mar2019 | - |
How is Total Non-Current Liabilities of BALAXI PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹3.66 Cr | 9,274.36 | |
Mar2022 | ₹0.04 Cr | 457.14 | |
Mar2021 | ₹0.01 Cr | 133.33 | |
Mar2020 | ₹0.00 Cr | 0 | |
Mar2019 | - | - |
Compare Total Non-Current Liabilities of peers of BALAXI PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BALAXI PHARMACEUTICALS | ₹656.8 Cr | -1% | 3.4% | 14.1% | Stock Analytics | |
ADANI ENTERPRISES | ₹326,052.0 Cr | -5.8% | -10.9% | 48.5% | Stock Analytics | |
REDINGTON | ₹16,096.7 Cr | -5.7% | -4.6% | 19.6% | Stock Analytics | |
HONASA CONSUMER | ₹14,000.9 Cr | 1.7% | 4.8% | NA | Stock Analytics | |
MMTC | ₹10,620.0 Cr | -5.5% | -6.1% | 128.2% | Stock Analytics | |
MSTC | ₹5,814.7 Cr | -7.4% | -11.7% | 174.3% | Stock Analytics |
BALAXI PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BALAXI PHARMACEUTICALS | -1% |
3.4% |
14.1% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses